<DOC>
	<DOCNO>NCT01543139</DOCNO>
	<brief_summary>This propose research aim investigate efficacy safety creatine cytidine augmentation treat bipolar depression evaluate change relevant brain biochemical metabolism use magnetic resonance spectroscopy .</brief_summary>
	<brief_title>Trial Combined Cytidine Creatine Treatment Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Men woman age 18 65 Diagnosis bipolar depression assess Structured Clinical Interview DSMIV ( SCIDIV ) Individuals provide write consent participation Present past use drug bipolar depression Presence major physical neurological illness ( e.g. , head trauma , epilepsy , seizure , stroke , cerebral tumor , multiple sclerosis , cerebrovascular disease , narrowangle glaucoma , drug hypersensitivity , etc . ) Diagnosis Axis I disorder bipolar disorder presence symptom require hospitalization Presence borderline personality disorder antisocial personality disorder Presence alcohol drug dependence Intelligence quotient 80 Contraindications magnetic resonance imaging ( e.g. , pacemaker implantation , claustrophobia , etc . ) Use psychoactive medication may affect brain imaging finding Women pregnant , breastfeeding , plan pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>